Your browser doesn't support javascript.
loading
SARS-CoV-2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays.
Renaud, Christian; Lewin, Antoine; Gregoire, Yves; Simard, Nathalie; Vallières, Émilie; Paquette, Maude; Drews, Steven J; O'Brien, Sheila F; Di Germanio, Clara; Busch, Michael P; Germain, Marc; Bazin, Renée.
Afiliação
  • Renaud C; Medical Affairs and Innovation, Héma-Québec, Montréal, Quebec, Canada.
  • Lewin A; Medical Affairs and Innovation, Héma-Québec, Montréal, Quebec, Canada.
  • Gregoire Y; Medical Affairs and Innovation, Héma-Québec, Montréal, Quebec, Canada.
  • Simard N; Medical Affairs and Innovation, Héma-Québec, Montréal, Quebec, Canada.
  • Vallières É; Division of Microbiology, Clinical Laboratory Medicine Department, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada.
  • Paquette M; Division of Infectious Diseases, Pediatrics Department, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada.
  • Drews SJ; Division of Microbiology, Clinical Laboratory Medicine Department, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada.
  • O'Brien SF; Division of Infectious Diseases, Pediatrics Department, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada.
  • Di Germanio C; Canadian Blood Services, Microbiology, Edmonton, Alberta, Canada.
  • Busch MP; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
  • Germain M; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
  • Bazin R; Vitalant Research Institute, San Francisco, California, USA.
Vox Sang ; 119(6): 533-540, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38577957
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurveys are typically analysed by applying a fixed threshold for seropositivity ('conventional approach'). However, this approach underestimates the seroprevalence of anti-nucleocapsid (N) in vaccinated individuals-who often exhibit a difficult-to-detect anti-N response. This limitation is compounded by delays between the onset of infection and sample collection. To address this issue, we compared the performance of four immunoassays using a new analytical approach ('ratio-based approach'), which determines seropositivity based on an increase in anti-N levels. MATERIALS AND

METHODS:

Two groups of plasma donors and four immunoassays (Elecsys total anti-N, VITROS total anti-N, Architect anti-N Immunoglobulin G (IgG) and in-house total anti-N) were evaluated. First-group donors (N = 145) had one positive SARS-CoV-2 polymerase chain reaction (PCR) test result and had made two plasma donations, including one before and one after the PCR test (median = 27 days post-PCR). Second-group donors (N = 100) had made two plasma donations early in the Omicron wave.

RESULTS:

Among first-group donors (97.9% vaccinated), sensitivity estimates ranged from 60.0% to 89.0% with the conventional approach, compared with 94.5% to 98.6% with the ratio-based approach. Among second-group donors, Fleiss's κ ranged from 0.56 to 0.83 with the conventional approach, compared with 0.90 to 1.00 with the ratio-based approach.

CONCLUSION:

With the conventional approach, the sensitivity of four immunoassays-measured in a predominantly vaccinated population based on samples collected ~1 month after a positive test result-fell below regulatory agencies requirement of ≥95%. The ratio-based approach significantly improved the sensitivities and qualitative agreement among immunoassays, to the point where all would meet this requirement.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Vox Sang Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Vox Sang Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá